Association between Circulating Inflammatory Proteins and Clinical Prognosis in Chinese Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer

J Thorac Oncol. 2019 Oct;14(10):e222-e224. doi: 10.1016/j.jtho.2019.05.027.

Authors

Rui Guan¹, Anqi Lin¹, Peng Luo¹, Jian Zhang²

Affiliations

¹ Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
² Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China. Electronic address: [email protected].

PMID: 31558232
DOI: 10.1016/j.jtho.2019.05.027

No abstract available

Publication types

Letter
Comment

MeSH terms

Black or African American
Carcinoma, Non-Small-Cell Lung*
ErbB Receptors / genetics
Humans
Inflammation
Lung Neoplasms*
Mutation
Prognosis

Substances

EGFR protein, human
ErbB Receptors